Seqster has launched 1-Click DataLake, a real-world data platform to expedite trial design, recruitment, and evidence generation for healthcare and life sciences.
The 1-Click DataLake draws on more than ten years of aggregated electronic health record (EHR) data, providing access to anonymised data from over 150 million patients and 200,000 clinicians across the US.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
By securely querying patient-consented records, the system offers real-time, longitudinal views of patient journeys that are designed to support advanced analytics and the creation of real-world evidence (RWE).
These insights are intended to aid trial design, feasibility assessments, and trial execution.
Seqster states that its queryable platform covers a wide range of practices and medical specialities. It also features deep integration with diverse and previously underserved populations.
This approach aligns with recent US Food and Drug Administration (FDA) mandates encouraging diversity in clinical trials, assisting sponsors in ensuring their studies better reflect the populations they aim to serve.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe platform includes robust patient populations in various therapeutic areas, supporting more accurate cohort selection and efficient recruitment methods.
Seqster is presenting 1-Click DataLake at the Precision Medicine World Conference 2026 during the AI and Data Sciences Showcase. The company describes its operating system as one that connects, cleanses, and transforms longitudinal health data for stakeholders in healthcare and life sciences.
Seqster CEO and co-founder Ardy Arianpour said: “We are turning health data into medicine for our clients. With longitudinal, research-ready data from more than 150 million patients, we’re now providing a turnkey real-world data infrastructure that accelerates study design, optimises patient recruitment, and enables evidence generation.
“By rapidly unlocking insights directly from real clinical encounters, our platform delivers a step-change in speed, scale, and intelligence across the clinical research lifecycle.”
Last month, SEQSTER announced the expansion of its partnership with Praxis Precision Medicines to expedite clinical trials in central nervous system disorders.
